Biography
Rafael Lozano, MD, MSc, is a Professor of Health Metrics Sciences and the Director of Health Systems at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
Dr. Lozano is a member of the National System of Researchers Level III (highest) in Mexico, the National Academy of Medicine of Mexico, and the Mexican Academy of Sciences. In 2015, he received the Medal of Health Merit from the Mexican Society of Public Health. In 2016 he was awarded the Health Award for Lifetime Achievement in Research by the Carlos Slim Foundation, and in 2017 he was recognized as Researcher of Excellence in Medical and Health Sciences by the Commission of the National Institutes of Health of the Ministry of Health in Mexico.
Prior to joining IHME, Dr. Lozano worked as director of the Centre of Health Systems Research at the National Institute of Public Health (2013–2017) and as the General Director of Health Information at the Ministry of Health in Mexico (2001–2007), where he coordinated the Health Information System for the Ministry of Health and the production of national health statistics. Overseeing the health information system, Dr. Lozano played a critical role in the construction of Mexico’s health reform through a systematic approach to evidence building. Prior to this, he worked at the World Health Organization (WHO) in Geneva as Senior Epidemiologist for the Global Program on Evidence for Health Policy for three years (1998–2001).
Dr. Lozano holds an MD from Universidad Nacional Autonoma de Mexico and a Master’s in Social Medicine from Universidad Autonoma Metropolitana in Mexico.
COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. The Lancet. 16 February 2023. doi: 10.1016/S0140-6736(22)02465-5.
Global Burden of Disease 2021 Health Financing Collaborator Network. Global investments in pandemic preparedness and COVID-19: tracking development assistance and domestic spending on health between 1990 and 2026. The Lancet Global Health. 24 January 2023. doi: 10.1016/S2214-109X(23)00007-4.
Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 10 October 2022. doi: 10.1001/jama.2022.18931.
GBD 2019 Healthcare Access and Quality Collaborators. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Global Health. 6 October 2022. doi: 10.1016/S2214-109X(22)00429-6.
Haakenstad A, Angelino O, Irvine CMS, et al. Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 21 July 2022. doi: 10.1016/S0140-6736(22)00936-9.
GBD 2019 Diabetes in the Americas Collaborators. Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Diabetes & Endocrinology. 15 July 2022. doi: 10.1016/S2213-8587(22)00186-3.
GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet. 14 July 2022. doi:10.1016/S0140-6736(22)00847-9.
GBD 2019 Human Resources for Health Collaborators. Measuring the availability of human resources for health and its relationship to universal health coverage: estimates for 204 countries and territories from 1990 to 2019. The Lancet. 23 May 2022. doi: 10.1016/S0140-6736(22)00532-3.
COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. The Lancet. 8 April 2022. doi: 10.1016/S0140-6736(22)00484-6.
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. The Lancet. 10 March 2022. doi: 10.1016/S0140-6736(21)02796-3.
GBD 2019 Ageing Collaborators. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 10 March 2022. doi: 10.1136/bmj-2021-068208.
The Gender Equality Metrics team and the COVID-19 Forecasting team at Institute for Health Metrics and Evaluation. Quantifying the effects of the COVID-19 pandemic on gender equality in health, social, and economic indicators. The Lancet. 2 March 2022. doi: 10.1016/S0140-6736(22)00008-3.
COVID-19 Forecasting Team. Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. The Lancet. 24 February 2022. doi: 10.1016/S0140-6736(21)02867-1.
COVID-19 National Preparedness Collaborators. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. The Lancet. 1 February 2022. doi:10.1016/S0140-6736(22)00172-6.
GBD 2019 Tuberculosis Collaborators. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. 23 September 2021. doi: 10.1016/S1473-3099(21)00449-7.
Global Burden of Disease 2020 Health Financing Collaborator Network. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. The Lancet. 22 September 2021. doi: 10.1016/S0140-6736(21)01258-7.
GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. The Lancet. 17 August 2021. doi: 10.1016/S0140-6736(21)01207-1.
Schneider MT, Chang AY, Crosby SW, Gloyd S, Harle AC, Lim S, Lozano R, Micah AE, Tsakalos G, Su Y, Murray CJL, Dieleman JL. Trends and outcomes in primary health care expenditures in low-income and middle-income countries, 2000–2017. BMJ Global Health. 12 August 2021. doi: 10.1136/bmjgh-2021-005798.
GBD 2020, Release 1, Vaccine Coverage Collaborators. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. The Lancet. 14 July 2021. doi: 10.1016/S0140-6736(21)00984-3.
Weaver MR, Nandakumar V, Joffe J, Barber RM, Fullman N, Singh A, Sparks GW, Yearwood J, Lozano R, Murray CJL, Ngo D. Variation in Health Care Access and Quality Among US States and High-Income Countries With Universal Health Insurance Coverage. JAMA Network Open. 28 June 202 doi: 10.1001/jamanetworkopen.2021.14730.
Fene F, Jesus Rios-Blancas M, Lachaud J, Razo C, Lamadrid-Figueroa H, Liu M, Michel J, Thermidor R, Lozano R. Life expectancy, death, and disability in Haiti, 1990-2017: a systematic analysis from the Global Burden of Disease Study 2017. Pan American Journal of Public Health. 2 November 2020. doi: 10.26633/RPSP.2020.136.
Gutierrez JP, Agudelo-Botero M, Garcia-Saiso S, Zepeda-Tena C, Davila-Cervantes CA, Gonzalez-Robledo MC, Fullman N, Razo C, Hernandez-Prado B, Martinez G, Barquera S, Lozano R. Advances and challenges on the path toward the SDGs: subnational inequalities in Mexico, 1990–2017. BMJ Global Health. 29 October 2020. doi: 10.1136/bmjgh-2020-002382.
IHME COVID-19 Forecasting Team. Modeling COVID-19 scenarios for the United States. Nature Medicine. 23 October 2020. doi:10.1038/s41591-020-1132-9.
Machado DB, Pescarini JM, Ramos D, Teixeira R, Lozano R, Pereira VOM, Azeredo C, Paes-Sousa R, Malta DC, Barreto ML. Monitoring the progress of health-related sustainable development goals (SDGs) in Brazilian states using the Global Burden of Disease indicators. Population Health Metrics. 30 September 2020. doi:10.1186/s12963-020-00207-2.
GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 27 August 2020. doi:10.1016/S0140-6736(20)30750-9.
Vollset SE, Goren E, Yuan C-W, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. The Lancet. 14 July 2020. doi:10.1016/S0140-6736(20)30677-2.
Global Burden of Disease Health Financing Collaborator Network. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3. The Lancet. 23 April 2020. doi:10.1016/S0140-6736(20)30608-5.
Híjar M, Pérez-Núñez R, Hidalgo-Solórzano E, Hernández Prado B, Valdez-Santiago R, Hamilton EB, James SL, Bertolacci GJ, Cunningham M, Dingels ZV, Fox JT, Liu Z, Roberts NLS, Sylte DO, Agudelo-Botero M, Borges G, Cahuana-Hurtado L, Campos-Nonato IR, Cardenas R, Davila-Cervantes CA, Denova-Guiterrez E, Diaz D, Lansingh VC, Martinez G, Montero-Zamora PA, Servan-Mori E, Lozano R. Unintentional injuries in Mexico, 1990–2017: findings from the Global Burden of Disease Study 2017. Injury Prevention. 1 April 2020. doi:10.1136/injuryprev-2019-043532.
GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. 22 January 2020. doi: 10.1016/S2468-1253(19)30349-8.
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet. 16 January 2020; doi: 10.1016/S0140-6736(19)32989-7.
GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2 April 2019. doi: 10.1016/S0140-6736(19)30041-8.
Naghavi M., on behalf of the Global Burden of Disease Self-Harm Collaborators. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ. 6 Feb 2019; 364:I94. doi:10.1136/bmj.l94.
GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1995-2051. doi: http://dx.doi.org/10.1016/S0140-6736(18)32278-5.
GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1684-735. doi: http://dx.doi.org/10.1016/S0140-6736(18)31891-9.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1736-88. doi: http://dx.doi.org/10.1016/S0140-6736(18)32203-7.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1789–858. doi: http://dx.doi.org/10.1016/S0140-6736(18)32279-7.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1859–922. doi: http://dx.doi.org/10.1016/S0140-6736(18)32335-3.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1923-94. doi: http://dx.doi.org/10.1016/S0140-6736(18)32225-6.
GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018; 392:2091–138. doi: http://dx.doi.org/10.1016/S0140-6736(18)32281-5.
Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories using data from the Global Burden of Disease Study 2016. The Lancet. 16 October 2018. doi:10.1016/S0140-6736(18)31694-5.
GBD 2016 Brazil Collaborators. Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. The Lancet. 20 July 2018. doi:10.1016/S0140-6736(18)31221-2.
Lamadrid-Figueroa H, Montoya A, Fritz J, Ortiz-Panozo E, González-Hernández D, Suárez-López L, Lozano R. Hospitals by day, dispensaries by night: Hourly fluctuations of maternal mortality within Mexican health institutions, 2010–2014. PLoS ONE. 31 May 2018. 13(5): e0198275. https://doi.org/10.1371/journal.pone.0198275
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 23 May 2018.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1345-1422.
GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1084–1150.
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1151–210.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390; 1211–59.
GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 12 Sept 2017: 390; 1423–59.
The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine. 12 Jun 2017. DOI: 10.1056/NEJMoa1614362
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1659–1724.
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1603–1658.
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1775–1812.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1459–1544.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1545–1602.
GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1725–1774.
Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2016 5 October.
Lim SS, Allen K, Bhutta ZA, et al. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet. 2016 Sep 21. doi: 10.1016/S0140-6736(16)31467-2.
Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, González-Robledo MC, Fitzmaurice C, Pain A, Allen C, Dicker DJ, Hamavid H, López A, Murray C, Naghavi M, Lozano R. The burden of cancer in Mexico, 1990-2013. Salud Pública de México. 2016 Mar.
Serina P, Riley I, Stewart A, et al. A shortened verbal autopsy instrument for use in routine mortality surveillance systems. BMC Medicine. 2015 Dec 16; 13:302. doi:10.1186/s12916-015-0528-8.
Serina P, Riley I, Stewart A, et al. Improving performance of the Tariff Method for assigning causes of death to verbal autopsies. BMC Medicine. 2015 Dec 8; 13:291. doi: 10.1186/s12916-015-0527-9.
Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 Sep 11. doi: 10.1016/S0140-6736(15)61455-6.
Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015 Aug 27. doi: 10.1016/S0140-6736(15)61340-X.
Mokdad AH, Gagnier MC, Colson KE, Zúñiga-Brenes P, Ríos-Zertuche D, Haakenstad A, Palmisano EB, Anderson BW, Desai SS, Gillespie CW, Murphy T, Naghavi P, Nelson J, Ranganathan D, Schaefer A, Usmanova G, Wilson S, Hernandez B, Lozano R, Iriarte E. Health and wealth in Mesoamerica: findings from Salud Mesoamérica 2015. BMC Medicine. 2015 Jul 14; 13:164. doi:10.1186/s12916-015-0393-5.
Colson KE, Zúñiga-Brenes P, Ríos-Zertuche D, Conde-Glez C, Gagnier MC, Palmisano E, Ranganathan D, Usmanova G, Salvatierra B, Nazar A, Tristao I, Sanchez Monin E, Anderson BW, Haakenstad A, Murphy T, Lim S, Hernandez B, Lozano R, Iriarte E, Mokdad AH. Comparative estimates of crude and effective coverage of measles immunization in low-resource settings: Findings from Salud Mesoamérica 2015. PLOS One. 2015 Jul 2. doi: 10.1371/journal.pone.0130697.
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 June 8. doi: 10.1016/S0140-6736(15)60692-4.
Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncology. 2015 May 28. doi: 10.1001/jamaoncol.2015.0735.
Phillips DE, AbouZahr C, Lopez AD, Mikkelsen L, de Savigny D, Lozano R, Wilmoth J, Setel PW. Are well functioning civil registration and vital statistics systems associated with better health outcomes? The Lancet. 2015 May 10. doi: 10.1016/S0140-6736(15)60172-6.
Mokdad AH, Colson KE, Zúñiga-Brenes P, et al. Salud Mesoamérica 2015 Initiative: design, implementation, and baseline findings. Population Health Metrics. 2015 Feb 7; 13:3. doi:10.1186/s12963-015-0034-4.
James SL, Romero M, Ramírez-Villalobos D, Gómez S, Pierce K, Flaxman A, Serina P, Stewart A, Murray CJL, Gakidou E, Lozano R, Hernandez B. Validating estimates of prevalence of non-communicable diseases based on household surveys: the symptomatic diagnosis study. BMC Medicine. 2015 Jan 26; 13:15. doi:10.1186/s12916-014-0245-8.
Kassebaum NJ, Lopez AD, Murray CJL, Lozano R. A comparison of maternal mortality estimates from GBD 2013 and WHO. The Lancet. 2014; 384:2209–2210.
Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 Dec 17. doi: 10.1016/S0140-6736(14)61682-2.
Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJL, Naghavi M. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine. 2014; 12:145.
Hotez PJ, Alvarado M, Basàñez M-G, et al. The Global Burden of Disease Study 2010: Interpretation and implications for the neglected tropical diseases. PLoS Neglected Tropical Diseases. 2014 Jul 24; 8(7): e2865. doi:10.1371/journal.pntd.0002865
Phillips DE, Lozano R, Naghavi M, Atkinson C, Gonzalez-Medina D, Mikkelsen L, Murray CJL, Lopez AD. A composite metric for assessing data on mortality and causes of death: the vital statistics performance index. Population Health Metrics. 2014 May 14. doi: 10.1186/1478-7954-12-14.
Shahraz S, Forouzanfar MH, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, Mokdad A, Lozano R, Vos T, Asadi-Lari M, Sayyari A, Murray CJL, Naghavi M. Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon. Archives of Iranian Medicine. 2014 May; 17(05).
Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, Mokdad A, Lozano R, Vos T, Asadi-Lari M, Sayyari A, Murray CJL, Naghavi M. Evaluating causes of death and morbidity in Iran, Global Burden of Diseases, Injuries, and Risk Factors Study 2010. Archives of Iranian Medicine. 2014 May; 17(05).
Naghavi M, Shahraz S, Sepanlou S, Dicker D, Naghavi P, Pourmalek F, Mokdad A, Lozano R, Vos T, Asadi-Lari M, Sayyari A, Murray CJL, Forouzanfar MH. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Archives of Iranian Medicine. 2014 May; 17(05).
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 May 2. doi: 10.1016/S0140-6736(14)60696-6.
Fullman N, Flaxman A, Leach-Kemon K, Rajaratnam JK, Lozano R. Measuring the world’s health: How good are our estimates? In: Brown GW, Yamey G, Wamala S, eds. The Handbook of Global Health Policy. John Wiley & Sons, Ltd, 2014: 97–117.
Murray CJL, Lozano R, Flaxman AD, et al. Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Medicine. 2014 Jan 9; 12(5). doi:10.1186/1741-7015-12-5
Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, Flaxman SR, Pullan RL, Brooker SJ, Murray CJL. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2013 Dec. DOI: 10.1182/blood-2013-06-508325.
Ortblad KF, Lozano R, Murray CJL. The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS. 2013; 27:2003–2017.
Murray CJL, Abraham J, Ali MK, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors [published online July 10, 2013]. Journal of the American Medical Association. DOI: 10.1001/jama.2013.13805.
Murray CJL, Richards MAR, Newton JN ,et al. UK health performance: findings of the Global Burden of Disease Study 2010. The Lancet.2013 March 5; http://dx.doi.org/10.1016/S0140-6736(13)60355-4.
Salomon JA, Vos T, Hogan DR, Gagnon M, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2129–2143.
Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2197–2223.
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2095–2128.
Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2224–2260.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2163–2196.
Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet. 2012; 379:413-431.
Foreman KJ, Lozano R, Lopez AD, Murray CJL. Modeling causes of death: an integrated approach using CODEm. Population Health Metrics. 2012; 10:1.
Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, Dwyer-Lindgren L, Lofgren KT, Phillips D, Atkinson C, Lopez AD, Murray CJL. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. The Lancet. 2011; 378:1139-1165.
Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. The Lancet. 2011; DOI:10.1016/S0140-6736(11)61351-2.
Murray CJL, Lopez AD, Black R, et al. Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Population Health Metrics. 2011; 9:27.
Murray CJL, Lozano R, Flaxman AD, Vahdatpour A, Lopez AD. Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Population Health Metrics. 2011; 9:28.
Hernandez B, Ramirez-Villalobos D, Romero M, Gomez S, Atkinson C, Lozano R. Assessing quality of medical death certification: concordance between gold standard diagnoses and underlying cause of death in selected Mexican hospitals. Population Health Metrics. 2011; 9:38.
Lozano R, Freeman MK, James SL, Campbell B, Lopez AD, Flaxman AD, Murray CJL, the Population Health Metrics Research Consortium (PHMRC). Performance of InterVA for assigning causes of death to verbal autopsies: multisite validation study using clinical diagnostic gold standards. Population Health Metrics. 2011; 9:50.
Lozano R, Lopez AD, Atkinson C, Naghavi M, Flaxman AD, Murray CJL, the Population Health Metrics Research Consortium (PHMRC). Performance of physician-certified verbal autopsies: multisite validation study using clinical diagnostic gold standards. Population Health Metrics. 2011; 9:32.
Murray CJL, James SL, Birnbaum JK, Freeman MK, Lozano R, Lopez AD, and the Population Health Metrics Research Consortium (PHMRC). Simplified Symptom Pattern Method for verbal autopsy analysis: multisite validation study using clinical diagnostic gold standards. Population Health Metrics. 2011; 9:30.
Birnbaum JK, Murray CJL, Lozano R. Exposing misclassified HIV/AIDS deaths in South Africa. Bulletin of the World Health Organization. 2011; 89:278-285.
Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJL. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Population Health Metrics. 2011; 9:8.
Gakidou E, Mallinger L, Abbott-Klafter J, Guerrero R, Villalpando S, Ridaura RL, Aekplakorn W, Naghavi M, Lim S, Lozano R, Murray CJL. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bulletin of the World Health Organization. 2011; 89:172-183.
Gakidou E, Cowling K, Lozano R, Murray CJL. Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. The Lancet. 2010 Sept 18; 376(9745):959-974. doi: 10.1016/S0140-6736(10)61257-3.
Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Population Health Metrics. 2010 May 10; 8:9.
Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, Lopez AD, Lozano R, Murray CJL. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. The Lancet. 2010 May 8; 375:1609–1623. Published online first April 12, 2010.
Bhalla K, Shahraz S, Naghavi M, Lozano R, Murray CJL. Estimating the distribution of external causes in hospital data from injury diagnosis. Accident Analysis and Prevention. 2008 Nov; 40(6):1822-1829.
Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. The Lancet. 2007 Dec 15; 370:2054–2062.
Murray CJL, Lopez AD, Barofsky JT, Bryson-Cahn C, Lozano R. Estimating population cause-specific mortality fractions from in-hospital mortality: validation of a new method. PLoS Medicine. 2007 Nov 20; 4(11):e326.
